SIXTH SUPPLEMENTAL INDENTURE, dated as of November 14, 2005 (this “Sixth Supplemental Indenture”), between WYETH (as successor to AMERICAN HOME PRODUCTS CORPORATION), a Delaware corporation (the “Issuer”) and JPMORGAN CHASE BANK, N.A. (as successor to...Supplemental Indenture • December 16th, 2005 • Wyeth • Pharmaceutical preparations • New York
has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, (iii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act and (iv) the Definitive Note is being acquired in compliance with any applicable blue sky securities laws of any state of the United States.
EXCHANGE AND REGISTRATION RIGHTS AGREEMENTExchange and Registration Rights Agreement • December 16th, 2005 • Wyeth • Pharmaceutical preparations • New York
Wyeth, a Delaware corporation (the “Company”), proposes to issue and sell to the several Initial Purchasers listed in Schedule I to the Purchase Agreement (the “Initial Purchasers”), upon the terms and subject to the conditions set forth in a purchase agreement dated November 8, 2005 between the Company and the Initial Purchasers (the “Purchase Agreement”), $1,000,000,000 aggregate principal amount of its 5.50% Notes due 2016 (the “2016 Notes”) and $500,000,000 aggregate principal amount of its 6.00% Notes due 2036 (the “2036 Notes” and collectively with the 2016 Notes, the “Notes”). Capitalized terms used but not defined herein shall have the meanings given to such terms in the Purchase Agreement.
